
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Description
Boehringer Ingelheim Venture Fund intends to invest in groundbreaking therapeutic approaches and technologies.
Investor Profile
Boehringer Ingelheim Venture Fund has made 91 investments, with 5 in the past 12 months and 49% as lead.
Stage Focus
- Series A (44%)
- Series B (25%)
- Seed (18%)
- Series C (8%)
- Series Unknown (4%)
- Pre Seed (1%)
Country Focus
- Germany (29%)
- United States (24%)
- Switzerland (11%)
- Belgium (9%)
- France (8%)
- United Kingdom (5%)
- China (3%)
- Sweden (2%)
- Israel (2%)
- Spain (2%)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Medical
- Life Science
- Oncology
- Medical Device
- Biopharma
- Pharmaceutical
- Artificial Intelligence (Ai)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.